Gregory T. Mayes, VP, Corporate Development and GC at UNIGENE LABORATORIES INC (UGNE), bought 2,000 shares at $0.53 ($1K) on 2011-12-21, disclosed to the SEC on 2011-12-22.
Open-market purchase of $1k UGNE by VP, Corporate Development and GC. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |